|Quantity Discounts||1 - 9999|
|1 - 9999|
|1 - 9999|
In fact, there have been so many important court rulings that your legal, regulatory affairs and compliance teams may be hard pressed to stay on top of them all.
Don’t put yourself at a dangerous disadvantage.
Instead, attend this webinar, featuring a top attorney who’ll bring you up to date on these major court cases and what they will mean for your business in 2011.
No matter how quickly the courts redefine and reinterpret complex rules, you can be sure that the FDA will expect your legal, regulatory and compliance team to keep you on top of the changes — and in compliance with what’s required.
With so much at stake, why not avoid the risk of noncompliance by registering for this timely FDAnews webinar?
In just 90 minutes, Alan Minsk, Partner at Arnall Golden Gregory, will define and address the compliance issues that will arise in 2011 from these specific cases:
Register now for Dissecting the Drug and Device Industries’ Leading Legal Cases and you’ll get expert guidance on:
A flexible fit for your busy schedule
The webinar is convenient to attend. All that’s required is that you be in front of a screen at the appointed time, whether at the office or telecommuting from an office-in-home.
Of course, Alan Minsk will be on hand to answer all of your questions. Simply submit your questions via email, and you’ll have answers by the time the session ends.
Key people on your legal, regulatory affairs and compliance teams will benefit from attending Dissecting the Drug and Device Industries’ Leading Legal Cases. Best of all, everyone can do so at a cost that won’t break the budget. You pay one single low registration fee per facility, regardless of how many participate. So spread the word to your entire team!
This webinar is offers valuable early-warning legal perspective to executives and personnel in medical device, pharmaceutical and biologics companies; CRO; and academic research organizations, including:
Alan Minsk is a Partner and Chair of the Food & Drug Practice Team of Arnall Golden Gregory LLP. He advises pharmaceutical and medical device companies on all legal and regulatory matters relating to the FDA, and certain matters concerning numerous other governmental agencies.
He counsels, speaks and writes on a wide variety of FDA-related issues, including product promotion and advertising, FDA enforcement, regulatory strategy and lifecycle management, market exclusivity, FDA inspections, corporate compliance, regulation of dietary supplements, product liability, imports and exports, and clinical trial issues. He also conducts in-house training on a wide variety of FDA and fraud and abuse-related topics.
He is also a past Leader of the RAPS Georgia Chapter, and is a member of numerous industry and legal associations. He earned his J.D. from the Georgetown University Law Center.
|Date:||April 4–22, 2011|
|Location:||Your office or conference room (no need to travel!)|
Gather your team for maximum benefit! Your investment is for one dial-in.
Significant tuition discounts are available for three or more sites from
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Registrations may not be cancelled. Please contact customer service to make any substitutions.
Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing